Jan 7 (Reuters) - The government of Australia has signed an advanced agreement to purchase 51 million doses of Novavax Inc's experimental COVID-19 vaccine, the company disclosed in a regulatory filing on Thursday. (https://bit.ly/35BGW3Z) (Reporting by Trisha Roy in Bengaluru; Editing by Shounak Dasgupta)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.4 USD | -4.32% | -20.75% | +200.00% |
Jun. 14 | Novavax Files Emergency Use Authorization Amendment For Updated COVID-19 Vaccine | MT |
Jun. 14 | FDA asks COVID vaccine makers to target KP.2 strain with updated shots | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+200.00% | 2.02B | |
+40.80% | 53.67B | |
+35.79% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |
- Stock Market
- Equities
- NVAX Stock
- News Novavax, Inc.
- Novavax : Australia enters agreement to buy 51 mln doses of Novavax's COVID-19 vaccine